Gene, Cell and Tissue

Published by: Kowsar

The Catechol-Methyltransferase rs4680 G>A Polymorphism is Associated with Uterine Leiomyoma Susceptibility

Mina Heydari 1 , Saeid Ghorbian 1 , * and Manizheh Sayyah Melli 2
Authors Information
1 Department of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran
2 Department of Obstetrics and Gynecology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • Gene, Cell and Tissue: January 31, 2019, 6 (1); e86258
  • Published Online: January 30, 2019
  • Article Type: Research Article
  • Received: November 10, 2018
  • Revised: January 26, 2019
  • Accepted: January 27, 2019
  • DOI: 10.5812/gct.86258

To Cite: Heydari M, Ghorbian S, Sayyah Melli M . The Catechol-Methyltransferase rs4680 G>A Polymorphism is Associated with Uterine Leiomyoma Susceptibility, Gene Cell Tissue. 2019 ; 6(1):e86258. doi: 10.5812/gct.86258.

Copyright © 2019, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Virchow R. Ueber makroglossie und pathologische neubildung quergestreifter muskelfasern. Archiv für pathologische anatomie und physiologie und für klinische medicin. 1854;7(1):126-38. German. doi: 10.1007/bf01936233.
  • 2. Ali M, Chaudhry ZT, Al-Hendy A. Successes and failures of uterine leiomyoma drug discovery. Expert Opin Drug Discov. 2018;13(2):169-77. doi: 10.1080/17460441.2018.1417381. [PubMed: 29254389].
  • 3. Francis JH, Kleinerman RA, Seddon JM, Abramson DH. Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol. 2012;124(2):254-9. doi: 10.1016/j.ygyno.2011.10.019. [PubMed: 22027510]. [PubMed Central: PMC3264733].
  • 4. Tuncal A, Aydin HH, Askar N, Ozkaya AB, Ergenoglu AM, Yeniel AO, et al. Increased expression of electron transport chain genes in uterine leiomyoma. Ann Clin Lab Sci. 2014;44(4):466-8. [PubMed: 25361934].
  • 5. Wang F, Chen J, Wang L, Ma Y, Mayinuer N. CYP1A1 genetic polymorphisms and uterine leiomyoma risk: A meta-analysis. Int J Clin Exp Med. 2015;8(3):3590-4. [PubMed: 26064254]. [PubMed Central: PMC4443088].
  • 6. Feng Y, Zhao X, Zhou C, Yang L, Liu Y, Bian C, et al. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM). Gene. 2013;529(2):296-9. doi: 10.1016/j.gene.2013.07.019. [PubMed: 23939469].
  • 7. Inoue S, Mizushima T, Miyamoto H. Role of the androgen receptor in urothelial cancer. Mol Cell Endocrinol. 2018;465:73-81. doi: 10.1016/j.mce.2017.06.021. [PubMed: 28652170].
  • 8. Taghizade Mortezaee F, Hashemzadeh Chaleshtori M, Kheiri S, Farrokhi E, Shariati L, Tabatabaiefar MA, et al. Interleukin-1 B gene polymorphisms in Iranian patients with uterine fibroid, a case- control study. Biosci Biot Res Asia. 2015;12(1):341-5. doi: 10.13005/bbra/1671.
  • 9. Mostafavi SS, Ebrahimi A, Sadat SM, Davari Tanha F, Aghasadeghi MR, Bahramali G, et al. Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population. J Obstet Gynaecol Res. 2016;42(4):434-9. doi: 10.1111/jog.12924. [PubMed: 26785830].
  • 10. Kotula-Balak M, Milon A, Pawlicki P, Opydo-Chanek M, Pacwa A, Lesniak K, et al. Insights into the role of estrogen-related receptors alpha, beta and gamma in tumor Leydig cells. Tissue Cell. 2018;52:78-91. doi: 10.1016/j.tice.2018.04.003. [PubMed: 29857832].
  • 11. Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. Genomics. 1992;12(4):822-5. doi: 10.1016/0888-7543(92)90316-K. [PubMed: 1572656].
  • 12. Ates O, Demirturk F, Toprak M, Sezer S. Polymorphism of catechol-o-methyltransferase and uterine leiomyoma. Mol Cell Biochem. 2013;375(1-2):179-83. doi: 10.1007/s11010-012-1540-3. [PubMed: 23238870].
  • 13. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34(13):4202-10. doi: 10.1021/bi00013a008. [PubMed: 7703232].
  • 14. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet. 1996;67(5):468-72. doi: 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G. [PubMed: 8886163].
  • 15. Zhu G, Lipsky RH, Xu K, Ali S, Hyde T, Kleinman J, et al. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5' nuclease assay. Psychopharmacology (Berl). 2004;177(1-2):178-84. doi: 10.1007/s00213-004-1938-z. [PubMed: 15290009].
  • 16. Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: Associations with differing cognitive operations. Biol Psychiatry. 2005;58(11):901-7. doi: 10.1016/j.biopsych.2005.05.010. [PubMed: 16043133].
  • 17. Diamond A, Briand L, Fossella J, Gehlbach L. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry. 2004;161(1):125-32. doi: 10.1176/appi.ajp.161.1.125. [PubMed: 14702260].
  • 18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi: 10.1093/nar/16.3.1215. [PubMed: 3344216]. [PubMed Central: PMC334765].
  • 19. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 1997;57(24):5493-7. [PubMed: 9407957].
  • 20. Ando T, Kato H, Furui T, Morishige KI, Goshima S, Matsuo M. Uterine smooth muscle tumours with hyperintense area on T1 weighted images: Differentiation between leiomyosarcomas and leiomyomas. Br J Radiol. 2018;91(1084):20170767. doi: 10.1259/bjr.20170767. [PubMed: 29308922]. [PubMed Central: PMC5966007].
  • 21. Dzhemlikhanova LK, Efimova OA, Osinovskaya NS, Parfenyev SE, Niauri DA, Sultanov IY, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for MED12 exon 2 mutations. J Clin Pathol. 2017;70(3):233-6. doi: 10.1136/jclinpath-2016-203976. [PubMed: 27491313].
  • 22. Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015;21(5):593-615. doi: 10.1093/humupd/dmv030. [PubMed: 26141720]. [PubMed Central: PMC4533663].
  • 23. Pietrowski D, Thewes R, Sator M, Denschlag D, Keck C, Tempfer C. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene. Am J Reprod Immunol. 2009;62(2):112-7. doi: 10.1111/j.1600-0897.2009.00718.x. [PubMed: 19614627].
  • 24. Hsieh YY, Chang CC, Tsai CH, Lin CC, Tsai FJ. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril. 2007;87(4):886-95. doi: 10.1016/j.fertnstert.2006.07.1541. [PubMed: 17222831].
  • 25. Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K, et al. Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol. 2008;35(1):35-40. [PubMed: 18390078].
  • 26. Denschlag D, Bentz EK, Hefler L, Pietrowski D, Zeillinger R, Tempfer C, et al. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril. 2006;85(2):462-7. doi: 10.1016/j.fertnstert.2005.07.1308. [PubMed: 16595228].
  • 27. Gooden KM, Schroeder JC, North KE, Gammon MD, Hartmann KE, Taylor J, et al. Val153Met polymorphism of catechol-O-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci. 2007;14(2):117-20. doi: 10.1177/1933719106298687. [PubMed: 17636223].
  • 28. de Oliveira E, de Aquino Castro R, Gomes MT, da Silva ID, Baracat EC, de Lima GR, et al. The catechol-O-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids. Maturitas. 2008;60(3-4):235-8. doi: 10.1016/j.maturitas.2008.07.001. [PubMed: 18752908].
  • 29. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006;13(2):136-44. doi: 10.1016/j.jsgi.2005.10.007. [PubMed: 16443508].
  • 30. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res. 1999;59(19):4870-5. [PubMed: 10519398].
  • 31. Zhao XM, Xie MQ, Yang DZ, Wang LA, Li SJ, Zhuang YY, et al. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer]. Zhonghua Fu Chan Ke Za Zhi. 2007;42(2):116-9. Chinese. [PubMed: 17442187].
  • 32. Juo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum Reprod. 2006;21(6):1498-502. doi: 10.1093/humrep/del033. [PubMed: 16527884].
  • 33. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis. 1998;19(1):1-27. doi: 10.1093/carcin/19.1.1. [PubMed: 9472688].
  • 34. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A. 1995;92(20):9220-4. doi: 10.1073/pnas.92.20.9220. [PubMed: 7568105]. [PubMed Central: PMC40956].
  • 35. Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet. 2008;25(8):389-94. doi: 10.1007/s10815-008-9246-x. [PubMed: 18763031]. [PubMed Central: PMC2582125].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments